4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-22-012159
Options or other derivatives
- SVP Finance; Interim CFO & PAO acquired 107,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Seline E. SVP Finance; Interim CFO & PAO | 2022-02-11 | Grant or award · Stock Option (Right to Buy) | +107,500 | 107,500 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…